Director Shareholding

GlaxoSmithKline PLC
25 April 2002


                              Director's Interests


I give below details of changes in interests in the Ordinary Share ADRs of
GlaxoSmithKline plc (each ADR represents two Ordinary Shares) in respect of the
under-mentioned director arising from the purchase of Ordinary Share ADRs on 18
April 2002 from the reinvestment of the dividend paid to Ordinary Share ADR
holders on the 18 April 2002 through the US Global BuyDirect Plan administered
by The Bank of New York:-


Mr D F McHenry      Beneficial interest in 0.1267 of an Ordinary Share ADR 
                    purchased at a price of $47.4401 per ADR.


                        Mr McHenry and the Company were advised of this
                        information on 24 April 2002.

S M Bicknell

Company Secretary

25 April 2002


                      This information is provided by RNS
            The company news service from the London Stock Exchange